Optomed Oyj Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of OPTOMED?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders98,2440.501%
Private Companies364,8581.86%
General Public8,652,31544.2%
Institutions10,480,25153.5%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 10.2%.


Top Shareholders

Top 25 shareholders own 55.76% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
8.82%
Skandinaviska Enskilda Banken AB, Asset Management Arm
1,728,813€7.2m0%1.09%
7.31%
OP Varainhoito Oy
1,432,956€6.0m0%0.06%
6.52%
Sp-Rahastoyhtiö Oy
1,278,107€5.3m45.3%0.24%
4.86%
Danske Capital Denmark
951,517€4.0m127%0.02%
3.53%
Cenova Capital
691,532€2.9m0%100.0%
3.52%
Joh. Berenberg, Gossler & Co. KG, Asset Management Arm
689,425€2.9m0%0.11%
3.51%
Aktia Kapitalforvaltning Ab
687,409€2.9m0%0.18%
3.07%
Finnish Industry Investment Ltd.
601,080€2.5m0%16.22%
2.87%
Elo Mutual Pension Insurance Company, Asset Management Arm
561,916€2.3m0%0.04%
2.55%
Handelsbanken Asset Management
499,894€2.1m0%no data
2.14%
Sampo Oyj, Asset Management Arm
419,382€1.7m0%0.26%
1.97%
Nordea Investment Management, AB
386,994€1.6m0%no data
1.97%
eQ Asset Management Ltd.
386,993€1.6m0%0.28%
1.86%
Joensuun Kauppa Ja Kone Oy
364,858€1.5m0%no data
0.42%
UB Fund Management Company Ltd.
82,510€343.7k0%0.09%
0.19%
Amundi Asset Management SAS
37,284€155.3k0%no data
0.15%
Laura Piila
30,000€125.0k1,400%no data
0.12%
Dimensional Fund Advisors LP
23,831€99.3k11.6%no data
0.083%
Petri Salonen
16,179€67.4k18.3%no data
0.078%
Reijo Tauriainen
15,271€63.6k8.91%no data
0.064%
Elite Fund Management Ltd
12,500€52.1k0%0.57%
0.062%
Seppo Makinen
12,192€50.8k11.4%no data
0.037%
Anna Tenstam
7,192€30.0k21%no data
0.029%
Lonvia Capital
5,619€23.4k0%0.01%
0.02%
Matias Rautionmaa
4,000€16.7k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 04:38
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Optomed Oyj is covered by 4 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kristofer Liljeberg-SvenssonCarnegie Investment Bank AB
Juha KinnunenInderes Oy
Gergana AlmquistRedeye